Negative symptom domain prevalence across diagnostic boundaries: The relevance of diagnostic shifts

Psychiatry Research

Volumn 228, Issue 3, 2015, Pages 347-354

  Lyne, John ^a,b,c   Renwick, Laoise ^a,b,c   O'Donoghue, Brian ^a,b,c   Kinsella, Anthony ^a,b,c   Malone, Kevin ^b,c   Turner, Niall ^a,b,c   O'Callaghan, Eadbhard ^a,b,c,d   Clarke, Mary ^a,b,c,d  

^a DETECT   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d St John of God Hospitaller Services Ireland   (Ireland)

Author keywords

Diagnosis; Negative symptoms; Persistent; Psychosis; Schizophrenia; Transdiagnostic

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHOTIC DISORDER; CONTROLLED STUDY; DELUSIONAL DISORDER; DIAGNOSIS; DIAGNOSTIC SHIFT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEGATIVE SYNDROME; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOM; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIA ASSESSMENT; SCHIZOPHRENIFORM DISORDER; SUBSTANCE INDUCED PSYCHOTIC DISORDER; BEHAVIOR; IRELAND; MIDDLE AGED; PSYCHOLOGY; PSYCHOTIC DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; BEHAVIORAL SYMPTOMS; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84938743577     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.05.086     Document Type: Article

References (58)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry Suppl. 1993, 22:39-44.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Arlington, VA. 4th ed.
3. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39:784-788.
4. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City, Iowa.
5. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) 1984, University of Iowa, Iowa City, Iowa.
6. Andreasen N.C. The concept of negative symptoms: definition, specificity, and significance. Psychiatr.Psychobiol. 1987, 11:240-251.
7. Andreasen N.C. Methods for assessing positive and negative symptoms. Mod. Probl. Pharmacopsychiatry 1990, 24:73-88.
8. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch. Gen. Psychiatry 1995, 52:341-351.
9. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005, 162:441-449.
10. Beiser M., Erickson D., Fleming J.A., Iacono W.G. Establishing the onset of psychotic illness. Am. J. Psychiatry 1993, 150:1349-1354.
11. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 2006, 32:238-245.
12. Bleuler E. Dementia Praecox or the Group of Schizophrenias 1950, International Universities Press, New York, NY.
13. Bottlender R., Sato T., Groll C., Jager M., Kunze I., Moller H.J. Negative symptoms in depressed and schizophrenic patients: how do they differ?. J.Clin. Psychiatry 2003, 64:954-958.
14. Bromet E.J., Kotov R., Fochtmann L.J., Carlson G.A., Tanenberg-Karant M., Ruggero C., Chang S.W. Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 2011, 168:1186-1194.
15. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 2007, 33:1013-1022.
16. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8:470-484.
17. Carpenter W.T. Porous diagnostic boundaries: a new emphasis for the bulletin. Schizophr. Bull. 2014, 40:1-2.
18. Cuthbert B.N., Insel T.R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013, 11:126.
19. Demjaha A., Morgan K., Morgan C., Landau S., Dean K., Reichenberg A., Sham P., Fearon P., Hutchinson G., Jones P.B., Murray R.M., Dazzan P. Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?. Psychol. Med. 2009, 39:1943-1955.
20. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders 1995, New York State Psychiatric Institute, New York.
21. Fischer B.A., Carpenter W.T. Will the Kraepelinian dichotomy survive DSM-V?. Neuropsychopharmacology 2009, 34:2081-2087.
22. Galderisi S., Bucci P., Mucci A., Kirkpatrick B., Pini S., Rossi A., Vita A., Maj M. Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. Schizophr. Res. 2013, 147:157-162.
23. Gerbaldo H., Georgi K., Pieschl D. The deficit syndrome in first-admission patients with psychotic and non-psychotic disorders. Eur. Psychiatry 1997, 12:53-57.
24. Gerbaldo H., Philipp M. The deficit syndrome in schizophrenic and nonschizophrenic patients: preliminary studies. Psychopathology 1995, 28:55-63.
25. Herbener E.S., Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients. Schizophr. Bull. 2001, 27:527-537.
26. Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophr. Res. 2011, 132:140-145.
27. Husted J.A., Beiser M., Iacono W.G. Negative symptoms and the early course of schizophrenia. Psychiatry Res. 1992, 43:215-222.
28. Kaiser S., Heekeren K., Simon J.J. The negative symptoms of schizophrenia: category or continuum?. Psychopathology 2011, 44:345-353.
29. Kamphuis J.H., Noordhof A. On categorical diagnoses in DSM-V: cutting dimensions at useful points?. Psychol. Assess. 2009, 21:294-301.
30. Kingston T., Scully P.J., Browne D.J., Baldwin P.A., Kinsella A., Russell V., O'Callaghan E., Waddington J.L. Diagnostic trajectory, interplay and convergence/divergence across all 12 DSM-IV psychotic diagnoses: 6-year follow-up of the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS). Psychol. Med. 2013, 1-11.
31. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., Carpenter W.T. The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res. 1989, 30:119-123.
32. Kirkpatrick B., Buchanan R.W., Ross D.E., Carpenter W.T. A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry 2001, 58:165-171.
33. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
34. Kirkpatrick B., Strauss G.P., Nguyen L., Fischer B.A., Daniel D.G., Cienfuegos A., Marder S.R. The brief negative symptom scale: psychometric properties. Schizophr. Bull. 2011, 37:300-305.
35. Kraepelin E. Dementia Praecox and Paraphrenia 1919, E and S Livingstone, Edinburgh, Scotland.
36. Lyne J., O'Donoghue B., Owens E., Renwick L., Madigan K., Kinsella A., Clarke M., Turner N., O'Callaghan E. Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophr. Res. 2012, 135:128-133.
37. Lyne J., Renwick L., Grant T., Kinsella A., McCarthy P., Malone K., Turner N., O'Callaghan E., Clarke M. Scale for the assessment of negative symptoms structure in first episode psychosis. Psychiatry Res. 2013, 210:1191-1197.
38. Lyne J., Renwick L., Madigan K., O'Donoghue B., Bonar M., Grant T., Kinsella A., Malone K., Turner N., O'Callaghan E., Clarke M. Do psychosis prodrome onset negative symptoms predict first presentation negative symptoms?. Eur. Psychiatry 2014, 29:153-159.
39. Makinen J., Miettunen J., Isohanni M., Koponen H. Negative symptoms in schizophrenia: a review. Nord. J. Psychiatry 2008, 62:334-341.
40. McGorry P., van Os J. Redeeming diagnosis in psychiatry: timing versus specificity. Lancet 2013, 381:343-345.
41. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., Malaspina D. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clin. Psychol. Rev. 2011, 31:161-168.
42. Moller H.J., Bottlender R., Gross A., Hoff P., Wittmann J., Wegner U., Strauss A. The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms. Schizophr. Res. 2002, 56:87-94.
43. Murphy B.P., Stuart A.H., McGorry P.D. Duration of untreated negative symptoms and duration of active negative symptoms: proof of concepts. Early Interv. Psychiatry 2008, 2:27-33.
44. Peralta V., Cuesta M.J. The deficit syndrome of the psychotic illness. A clinical and nosological study. Eur. Arch. PsychiatryClin. Neurosci. 2004, 254:165-171.
45. Peralta V., Cuesta M.J., Martinez-Larrea A., Serrano J.F. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am. J. Psychiatry 2000, 157:1461-1466.
46. Peralta V., Moreno-Izco L., Sanchez-Torres A., Garcia de J.E., Campos M.S., Cuesta M.J. Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs. Schizophr. Bull. 2014, 40:214-224.
47. Rabany L., Weiser M., Werbeloff N., Levkovitz Y. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophr. Res. 2011, 126:226-230.
48. Ramirez N., Arranz B., Salavert J., Alvarez E., Corripio I., Duenas R.M., Perez V., San L. Predictors of schizophrenia in patients with a first episode of psychosis. Psychiatry Res. 2010, 175:11-14.
49. Roche E., Clarke M., Browne S., Turner N., McTuige O., Kamali M., Kinsella A., Larkin C., Waddington J.L., O'Callaghan E. Prevalence and clinical correlates of depression in the acute of first episode schizophrenia. Irish J.Psychol. Med. 2010, 27:15-18.
50. Rosen C., Marvin R., Reilly J.L., Deleon O., Harris M.S., Keedy S.K., Solari H., Weiden P., Sweeney J.A. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression. Clin. Schizophr. Relat. Psychos. 2012, 6:145-151A.
51. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychol. Assess. 1996, 8:269-280.
52. Schwartz J.E., Fennig S., Tanenberg-Karant M., Carlson G., Craig T., Galambos N., Lavelle J., Bromet E.J. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch. Gen. Psychiatry 2000, 57:593-600.
53. Strauss G.P., Horan W.P., Kirkpatrick B., Fischer B.A., Keller W.R., Miski P., Buchanan R.W., Green M.F., Carpenter W.T. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J. Psychiatr. Res. 2013, 47:783-790.
54. Toomey R., Faraone S.V., Simpson J.C., Tsuang M.T. Negative, positive, and disorganized symptom dimensions in schizophrenia, major depression, and bipolar disorder. J. Nerv. Ment. Dis. 1998, 186:470-476.
55. van Os J., Burns T., Cavallaro R., Leucht S., Peuskens J., Helldin L., Bernardo M., Arango C., Fleischhacker W., Lachaux B., Kane J.M. Standardized remission criteria in schizophrenia. Acta Psychiatr. Scand. 2006, 113:91-95.
56. Wagman A.M., Heinrichs D.W., Carpenter W.T. Deficit and nondeficit forms of schizophrenia: neuropsychological evaluation. Psychiatry Res. 1987, 22:319-330.
57. Whitty P., Clarke M., McTigue O., Browne S., Kamali M., Larkin C., O'Callaghan E. Diagnostic stability four years after a first episode of psychosis. Psychiatr. Serv. 2005, 56:1084-1088.
58. WHO The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and DIagnostic Guidelines 1992, World Health Organisation, Geneva. 10th ed.